ONPATTRO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 07 Feb 2025)
What this means for you
Registered since 30 Oct 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86944919
- Registration number
- 5596122
- Mark type
- Stylized text
- Filed
- 18 Mar 2016
- Published for opposition
- 09 Aug 2016
- Registered
- 30 Oct 2018
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the treatment of familial amyloidotic polyneuropathy
Owner
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 07 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Sept 2024 — TEAS SECTION 8 & 15 RECEIVED
- 30 Oct 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 30 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 22 Sept 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Sept 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Aug 2018 — USE AMENDMENT FILED
- 09 Sept 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Aug 2018 — TEAS STATEMENT OF USE RECEIVED
- 16 Mar 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Mar 2018 — SOU EXTENSION 3 GRANTED
- 14 Mar 2018 — SOU EXTENSION 3 FILED